STAGE IB HEPATOCELLULAR CARCINOMA AJCC V8
Clinical trials for STAGE IB HEPATOCELLULAR CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IB HEPATOCELLULAR CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IB HEPATOCELLULAR CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo aims to shrink tough liver tumors
Disease control OngoingThis study is testing if a combination of two drugs, regorafenib and durvalumab, can shrink tumors in adults with high-risk liver cancer. The goal is to see if this treatment makes surgery more effective or possible. Patients receive the drugs for up to two years and are then mon…
Matched conditions: STAGE IB HEPATOCELLULAR CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New drug duo aims to wipe out liver cancer before surgeons even operate
Disease control OngoingThis study is testing whether giving two immunotherapy drugs before surgery can help people with operable liver cancer. The drugs, atezolizumab and bevacizumab, aim to help the body's immune system attack the cancer and cut off its blood supply. Researchers hope this pre-surgery …
Matched conditions: STAGE IB HEPATOCELLULAR CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC